High-Dose Cyclophosphamide for Steroid Refractory GVHD
Clinical trial NCT00492921 · COMPLETED
Trial details
- NCT number
- NCT00492921
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2013-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.